计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Atuliflapon (AZD5718) is an orally active inhibitor of FLAP (5‑Lipoxygenase activating protein) , with an IC 50 of 2 nM. Atuliflapon is used in the study for coronary artery disease
In Vitro
Atuliflapon demonstrates a dose dependent and greater than 90% suppression of leukotriene production over 24 h. Atuliflapon exhibits an IC 50 of 39 nM for LTB 4. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Atuliflapon exhibits t1/2 of 0.45 h and 2.1 h in rat and dog by iv injection, respectively . Atuliflapon shows no inhibition of 5-LO pathway activity in rodent blood . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:IC50: 2 nM (FLAP)